Diagnoses and treatment protocols for the survivors of ALL and other malignancies
| Diagnosis | Protocol | No | Anthracycline dose (mg/m2) | No receiving cranial irradiation dose: | |||||
|---|---|---|---|---|---|---|---|---|---|
| 24 Gy | ⩽18 Gy | ||||||||
| ALL | |||||||||
| ALL | UKALL X | 24 | 90–270 | 3 | 21 | ||||
| UKALL VIII | 8 | 0–90 | — | 8 | |||||
| UKALL VI | 2 | 0 | 2 | — | |||||
| NHL | UKCCSG NHL | 1 | 330 | — | 1 | ||||
| Other malignancies | |||||||||
| AML | AML 10 | 4 | 300 | — | — | ||||
| AML 9 | 2 | 450 | — | — | |||||
| AML 8 | 1 | 450 | — | — | |||||
| NHL | CHOP | 1 | 200 | — | — | ||||
| NHL 904 | 1 | 270 | — | — | |||||
| Wilms’ tumour | UKWM 1 | 3 | — | — | — | ||||
| UKWM 2 | 3 | — | — | — | |||||
| Neuroblastoma | OPEC | 2 | — | — | — | ||||
| Yolk sac | JEB/BEP | 2 | — | — | — | ||||
| Rhabdomyosarcoma | MMT 89 | 1 | — | — | — | ||||
| Hodgkin’s lymphoma | CLVPP | 1 | — | — | — | ||||
AML=acute myeloid leukaemia; NHL=non-Hodgkin’s lymphoma.